Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis - Concepedia

Concepedia

Publication | Open Access

Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis

DOI Full Paper Access

63

Citations

19

References

2011

Year

Kyung‐Hee Kim, Andreas Maderna, Mark E. Schnute, Martin Hegen, Shashi Mohan, Joy Miyashiro, Laura Lin, Evelyn Li, Sean Keegan, Jennifer Lussier,

Bioorganic & Medicinal Chemistry Letters

Rheumatoid DisorderRheumatologyMedicinal ChemistryAnti-inflammatoryMedicineImmunologyInflammatory Rheumatic DiseasePharmacotherapyDrug DevelopmentPharmacologyIrreversible Btk InhibitorsRheumatoid ArthritisDrug Discovery

References

	Year	Citations

Page 1

Page 1